Search research articles
Contact Us
Filters
Showing results (201-210 of 221) with videos related to
Page
of 23
Sort By:
Cancer Research
|
December 18, 2004
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia
Mohamed Bentires-Alj, J Guillermo Paez, Frank S David, et al.
JCO Precision Oncology
|
February 8, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung Cancer
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
Alexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Cancer Discovery
|
September 16, 2015
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors
Haiying Cheng, Yiyu Zou, Jeffrey S Ross, et al.
Cancer Cell
|
November 28, 2021
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
Lauren C Shapiro, Astha Thakkar, Sean T Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
JAMA Oncology
|
May 29, 2025
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung Cancer
Arianna Marinello, Maria Rosa Ghigna, Julia K Rotow, et al.
Cancer
|
August 26, 2025
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024
Narjust Florez, Sandip Patel, Heather A Wakelee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 23, 2023
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)
Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 221) with videos related to
Sort By:
Page
of 23
Cancer Research
|
December 18, 2004
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia
Mohamed Bentires-Alj, J Guillermo Paez, Frank S David, et al.
JCO Precision Oncology
|
February 8, 2024
Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non-Small-Cell Lung Cancer
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
Alexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Cancer Discovery
|
September 16, 2015
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors
Haiying Cheng, Yiyu Zou, Jeffrey S Ross, et al.
Cancer Cell
|
November 28, 2021
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
Lauren C Shapiro, Astha Thakkar, Sean T Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
JAMA Oncology
|
May 29, 2025
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung Cancer
Arianna Marinello, Maria Rosa Ghigna, Julia K Rotow, et al.
Cancer
|
August 26, 2025
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024
Narjust Florez, Sandip Patel, Heather A Wakelee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 23, 2023
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)
Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, et al.
Page
of 23